[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].

F, Duckert; G, Müller; E O, Meili

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1975

Data sources: Europe PubMed Central

[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].

descriptionPublicationkeyboard_double_arrow_right Article 11 Oct 1975 German Journal:Schweizerische medizinische Wochenschrift, volume 101 (issn: 0036-7672,

Copyright policy )

Authors: F, Duckert; G, Müller; E O, Meili;

pmid: 5173501

[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Adult, Male, Hemostasis, Factor VIII, Dose-Response Relationship, Drug, Fibrinogen, Blood Donors, Hemorrhage, Middle Aged, Hemophilia A, Surgical Procedures, Operative, Preoperative Care, Humans, Wounds and Injuries, Female, Infusions, Parenteral, Child, Blood Coagulation

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%

Found an issue? Give us feedback

5

Average

Top 10%

Upload OA version

Are you the author of this publication? Upload your Open Access version to Zenodo!

It’s fast and easy, just two clicks!

uploadUpload now